FDA Orders Suicide Warnings On Epilepsy Drugs

Law360, New York (December 17, 2008, 12:00 AM EST) -- Epilepsy drugs must now be labeled with warnings about the risk of suicidal thoughts and behavior associated with the medications, the U.S. Food and Drug Administration announced Wednesday.

Epilepsy-drug makers will also be required to submit risk evaluation and mitigation reports that include a medication guide for patients with information about suicide risks associated with anti-epileptic drugs, the FDA said.

The new labeling requirement will affect all anti-epileptic drugs, including Carbatrol, Klonopin, Tranxene, Depakote, Zarontin, Paganone, Felbatol, Neurontin, Lamictal, Vimpat, Keppra, Mesantoin, Celotin, Trileptal, Lyrica, Topamax,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.